BMRN Cash Flow Statement

Click line-items for a historical chart and %
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) -39.81M
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization 11.56M
Amortization of discount on investments 1.46M
Equity in the loss of BioMarin/Genzyme LLC 401K
Stock-based compensation 11.51M
Net gain from sale of investments
Deferred income taxes -43K
Excess tax benefit from stock option exercises -128K
Unrealized foreign exchange (gain) loss on forward contracts -364K
Changes in the fair value of contingent acquisition consideration payable 4.75M
Changes in operating assets and liabilities:
Accounts receivable, net -11.28M
Inventory -7.13M
Other current assets
Other assets -1.02M
Accounts payable and accrued liabilities -6.73M
Other long-term liabilities 2.77M
Net cash provided by operating activities -32.03M
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment -11.83M
Maturities and sales of investments 82.53M
Purchase of available-for-sale investments -68.77M
Business acquisitions, net of cash acquired -9.88M
Investments in BioMarin/Genzyme LLC 0
Net cash provided by (used in) investing activities -7.94M
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Employee Stock Purchase Plan (ESPP) and exercise of stock options 24.36M
Excess tax benefit from stock option exercises 128K
Payment of contingent acquisition consideration payable
Repayment of capital lease obligations -143K
Net cash provided by financing activities 13.82M
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS -26.15M
Cash and cash equivalents:
Beginning of period 180.53M
End of period 154.38M
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Cash paid for interest, net of interest capitalized into fixed assets 2M
Cash paid for income taxes 646K
Stock-based compensation capitalized into inventory 993K
Depreciation capitalized into inventory
SUPPLEMENTAL CASH FLOW DISCLOSURES FROM INVESTING AND FINANCING ACTIVITIES:
Changes in accrued liabilities related to fixed assets -6.41M
Equipment acquired through capital leases

Entities mentioned with BMRN

View All Entities